OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy
Loredana Cifaldi, Ombretta Melaiu, Roberto Giovannoni, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14

Showing 14 citing articles:

CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies
Zhipu Niu, Jingyuan Wu, Qiancheng Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10

Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapies
Christina Angeliki Tsiverioti, Adrian Gottschlich, Marcel P. Trefny, et al.
Biological Chemistry (2024) Vol. 405, Iss. 7-8, pp. 485-515
Open Access | Times Cited: 8

The Combination of Bioavailable Concentrations of Curcumin and Resveratrol Shapes Immune Responses While Retaining the Ability to Reduce Cancer Cell Survival
Chiara Focaccetti, Camilla Palumbo, Monica Benvenuto, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 232-232
Open Access | Times Cited: 13

The antiviral potential of Vγ9Vδ2 T cells: Therapeutic implications for immunocompromised adult and pediatric hosts
Veronica Bordoni, Federica Guarracino, Alessandro Lorusso, et al.
International review of cell and molecular biology (2025)
Closed Access

The Role of NK Cells in Cancer Immunotherapy: Mechanisms, Evasion Strategies, and Therapeutic Advances
Paula Morcillo-Martín-Romo, Javier Valverde-Pozo, María Ortiz-Bueno, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 857-857
Open Access

Harnessing natural killer cell effector function against cancer
Matthew D. Blunt, Salim I. Khakoo
Immunotherapy Advances (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 9

Advancements in strategies for overcoming the blood–brain barrier to deliver brain-targeted drugs
Zhichuang Qu, Juan Luo, Zheng Li, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 2

CAR Cells beyond Classical CAR T Cells: Functional Properties and Prospects of Application
Elizaveta P. Minina, Dmitry V. Dianov, Saveliy A. Sheetikov, et al.
Biochemistry (Moscow) (2024) Vol. 89, Iss. 5, pp. 765-783
Closed Access

Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
Mohadeseh Mohammad Taheri, Fatemeh Javan, Mohadeseh Poudineh, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access

New Insights into the Potential Role of Chimeric Activating Receptors-Engineered Natural Killer Cells to Fight Cancer
Loredana Cifaldi, Laura Masuelli, Roberto Bei
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 8
Open Access

Engineering and targeting potential of CAR NK cells in colorectal cancer
Muhammad Babar Khawar, Ali Afzal, Shuangshuang Dong, et al.
Chinese Medical Journal (2024)
Open Access

CAR beyond the classical CAR-T: functional features and application prospects (review)
Elizaveta P. Minina, Dmitry V. Dianov, Saveliy A. Sheetikov, et al.
Биохимия (2024) Vol. 89, Iss. 5, pp. 733-754
Closed Access

Exercise: a non-drug strategy of NK cell activation
Huixin Pan, Rui Meng, Zixuan Jia, et al.
Brazilian Journal of Medical and Biological Research (2024) Vol. 57
Open Access

Page 1

Scroll to top